Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / FundiShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
IssuerBlackrock
Entity holding fund iShares VII Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF TickerCUS1(GBX) LSE
ETF TickerCUSS(USD) LSE
ETF TickerSXRG(EUR) F
ETF TickerCSUSS.MI(EUR) CXE
ETF TickerCSUSSz(USD) CXE
ETF TickerCUSS.LS(USD) CXE
ETF TickerCSUSS(EUR) ETF Plus
ETF TickerCUS1.L(GBP) LSE
ETF TickerCUSS.L(GBP) LSE

Holdings detail for RNA

Stock NameAvidity Biosciences Inc
TickerRNA(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS05370A1088

Show aggregate RNA holdings

News associated with RNA

Avidity Biosciences, Inc. (NASDAQ:RNA) Shares Purchased by Hsbc Holdings PLC
Hsbc Holdings PLC lifted its holdings in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 111.4% in the 4th quarter, Holdings Channel.com reports. The fund owned 17,519 shares of the biotechnology company’s stock after buying an additional 9,230 shares during the quarter. Hsbc Holdings PLC’s holdings in Avidity Biosciences were worth $507,000 at the end […] - 2025-05-07 08:00:55
First Trust Advisors LP Buys 45,254 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
First Trust Advisors LP lifted its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 110.0% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 86,395 shares of the biotechnology company’s stock after acquiring an additional 45,254 shares during the period. First Trust Advisors LP […] - 2025-05-05 08:08:59
Envestnet Asset Management Inc. Sells 3,931 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
Envestnet Asset Management Inc. decreased its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 10.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 33,132 shares of the biotechnology company’s stock after selling 3,931 shares during the quarter. Envestnet […] - 2025-05-02 07:24:46
Raymond James Financial Inc. Makes New $5.78 Million Investment in Avidity Biosciences, Inc. (NASDAQ:RNA)
Raymond James Financial Inc. purchased a new stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 198,907 shares of the biotechnology company’s stock, valued at approximately $5,784,000. Other hedge funds and […] - 2025-04-25 09:43:06
Legal & General Group Plc Has $2.97 Million Stake in Avidity Biosciences, Inc. (NASDAQ:RNA)
Legal & General Group Plc lifted its position in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 7.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 102,100 shares of the biotechnology company’s stock after purchasing an additional 6,937 shares […] - 2025-04-24 08:06:51
Summit Investment Advisors Inc. Buys 666 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
Summit Investment Advisors Inc. raised its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 6.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,611 shares of the biotechnology company’s stock after purchasing an additional 666 shares during the period. […] - 2025-04-21 07:56:51
Renaissance Technologies LLC Acquires 69,300 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
Renaissance Technologies LLC lifted its holdings in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 48.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 211,200 shares of the biotechnology company’s stock after acquiring an additional 69,300 shares during the period. Renaissance […] - 2025-04-20 08:00:56
Alliancebernstein L.P. Decreases Position in Avidity Biosciences, Inc. (NASDAQ:RNA)
Alliancebernstein L.P. decreased its holdings in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 25.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 127,770 shares of the biotechnology company’s stock after selling 42,914 shares during the quarter. Alliancebernstein L.P.’s holdings in Avidity […] - 2025-04-15 07:50:50
Avidity Biosciences, Inc. (NASDAQ:RNA) Shares Sold by JPMorgan Chase & Co.
JPMorgan Chase & Co. reduced its position in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 3.6% in the 4th quarter, Holdings Channel reports. The firm owned 450,144 shares of the biotechnology company’s stock after selling 16,941 shares during the period. JPMorgan Chase & Co.’s holdings in Avidity Biosciences were worth $13,090,000 as of its […] - 2025-04-14 08:13:06
Needham & Company LLC Reaffirms “Buy” Rating for Avidity Biosciences (NASDAQ:RNA)
Avidity Biosciences (NASDAQ:RNA – Get Free Report)‘s stock had its “buy” rating restated by Needham & Company LLC in a report released on Wednesday,Benzinga reports. They currently have a $60.00 target price on the biotechnology company’s stock. Needham & Company LLC’s target price would indicate a potential upside of 148.86% from the stock’s current price. […] - 2025-04-11 09:22:53
Sei Investments Co. Sells 19,149 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
Sei Investments Co. lessened its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 47.0% during the 4th quarter, HoldingsChannel.com reports. The fund owned 21,554 shares of the biotechnology company’s stock after selling 19,149 shares during the period. Sei Investments Co.’s holdings in Avidity Biosciences were worth $627,000 as of its most […] - 2025-04-09 07:28:50
Avidity Biosciences, Inc. (NASDAQ:RNA) Shares Purchased by Schroder Investment Management Group
Schroder Investment Management Group boosted its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 99.7% in the fourth quarter, Holdings Channel reports. The fund owned 61,480 shares of the biotechnology company’s stock after purchasing an additional 30,697 shares during the period. Schroder Investment Management Group’s holdings in Avidity Biosciences were worth […] - 2025-04-07 08:46:59
Mitsubishi UFJ Asset Management Co. Ltd. Has $171,000 Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA)
Mitsubishi UFJ Asset Management Co. Ltd. decreased its stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 36.9% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,621 shares of the biotechnology company’s stock after selling 3,292 shares during […] - 2025-04-04 08:55:03
KLP Kapitalforvaltning AS Acquires New Position in Avidity Biosciences, Inc. (NASDAQ:RNA)
KLP Kapitalforvaltning AS purchased a new position in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 17,900 shares of the biotechnology company’s stock, valued at approximately $521,000. Other institutional investors and hedge funds […] - 2025-04-04 07:46:49
Avidity Biosciences, Inc. (NASDAQ:RNA) Shares Sold by Corient Private Wealth LLC
Corient Private Wealth LLC lowered its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 6.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 10,525 shares of the biotechnology company’s stock after selling 731 shares during the quarter. […] - 2025-04-01 07:32:50
Cibc World Markets Corp Acquires New Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA)
Cibc World Markets Corp bought a new stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 10,386 shares of the biotechnology company’s stock, valued at approximately $302,000. A number of other […] - 2025-03-25 08:48:52
Raymond James Financial Inc. Acquires Shares of 198,907 Avidity Biosciences, Inc. (NASDAQ:RNA)
Raymond James Financial Inc. bought a new stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) during the 4th quarter, HoldingsChannel.com reports. The institutional investor bought 198,907 shares of the biotechnology company’s stock, valued at approximately $5,784,000. Other hedge funds have also recently made changes to their positions in the company. Victory Capital Management Inc. […] - 2025-03-25 08:08:48
Avidity Biosciences, Inc. (NASDAQ:RNA) Receives $66.69 Average Target Price from Analysts
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) has received a consensus rating of “Buy” from the thirteen research firms that are covering the company, MarketBeat.com reports. Thirteen analysts have rated the stock with a buy recommendation. The average 1 year price objective among brokers that have covered the stock in the last year is […] - 2025-03-21 05:20:54
Chardan Capital Reaffirms Buy Rating for Avidity Biosciences (NASDAQ:RNA)
Chardan Capital reissued their buy rating on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a research note published on Monday,Benzinga reports. The firm currently has a $65.00 price target on the biotechnology company’s stock. Other analysts have also recently issued research reports about the company. Scotiabank began coverage on Avidity Biosciences in a […] - 2025-03-18 05:54:46
Avidity Biosciences (NASDAQ:RNA) Earns Sector Outperform Rating from Analysts at Scotiabank
Scotiabank began coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a report issued on Friday morning, MarketBeat Ratings reports. The brokerage issued a sector outperform rating and a $70.00 target price on the biotechnology company’s stock. Other analysts also recently issued research reports about the company. Chardan Capital reaffirmed a “buy” rating […] - 2025-03-10 05:50:51
Avidity Biosciences (NASDAQ:RNA) Shares Gap Down After Analyst Downgrade
Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report)’s stock price gapped down before the market opened on Monday after Barclays lowered their price target on the stock from $63.00 to $57.00. The stock had previously closed at $30.64, but opened at $29.90. Barclays currently has an overweight rating on the stock. Avidity Biosciences shares last […] - 2025-03-04 06:37:23
Barclays Cuts Avidity Biosciences (NASDAQ:RNA) Price Target to $57.00
Avidity Biosciences (NASDAQ:RNA – Free Report) had its target price cut by Barclays from $63.00 to $57.00 in a research report sent to investors on Friday morning,Benzinga reports. They currently have an overweight rating on the biotechnology company’s stock. Other equities research analysts also recently issued reports about the stock. Needham & Company LLC reissued […] - 2025-03-03 06:48:54
New York State Common Retirement Fund Buys 598 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
New York State Common Retirement Fund raised its stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 0.3% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 184,811 shares of the biotechnology company’s stock after acquiring an additional 598 shares during the period. […] - 2025-02-28 09:04:58
Avidity Biosciences, Inc. (NASDAQ:RNA) Shares Bought by State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D lifted its stake in shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 8.1% during the fourth quarter, Holdings Channel reports. The firm owned 48,536 shares of the biotechnology company’s stock after buying an additional 3,638 shares during the period. State of New Jersey Common Pension […] - 2025-02-26 08:31:05
Analysts Set Avidity Biosciences, Inc. (NASDAQ:RNA) PT at $65.80
Shares of Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) have earned a consensus recommendation of “Buy” from the ten ratings firms that are currently covering the stock, Marketbeat.com reports. Ten analysts have rated the stock with a buy recommendation. The average 12-month price objective among brokerages that have covered the stock in the last […] - 2025-02-24 06:30:54
abrdn plc Buys 20,076 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
abrdn plc raised its stake in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 80.8% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 44,912 shares of the biotechnology company’s stock after purchasing an additional 20,076 shares during the period. abrdn plc’s holdings in […] - 2025-02-11 08:24:48

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc RNA holdings

DateNumber of RNA Shares HeldBase Market Value of RNA SharesLocal Market Value of RNA SharesChange in RNA Shares HeldChange in RNA Base ValueCurrent Price per RNA Share HeldPrevious Price per RNA Share Held
2025-05-08 (Thursday)39,830USD 1,142,723USD 1,142,723
2025-05-07 (Wednesday)39,830USD 1,042,351RNA holding decreased by -3585USD 1,042,3510USD -3,585 USD 26.17 USD 26.26
2025-05-06 (Tuesday)39,830USD 1,045,936RNA holding decreased by -239776USD 1,045,9360USD -239,776 USD 26.26 USD 32.28
2025-05-05 (Monday)39,830USD 1,285,712RNA holding increased by 3186USD 1,285,7120USD 3,186 USD 32.28 USD 32.2
2025-05-02 (Friday)39,830USD 1,282,526RNA holding decreased by -19517USD 1,282,5260USD -19,517 USD 32.2 USD 32.69
2025-05-01 (Thursday)39,830USD 1,302,043RNA holding increased by 1593USD 1,302,0430USD 1,593 USD 32.69 USD 32.65
2025-04-30 (Wednesday)39,830RNA holding decreased by -135USD 1,300,450RNA holding increased by 15176USD 1,300,450-135USD 15,176 USD 32.65 USD 32.16
2025-04-29 (Tuesday)39,965USD 1,285,274RNA holding increased by 38166USD 1,285,2740USD 38,166 USD 32.16 USD 31.205
2025-04-28 (Monday)39,965USD 1,247,108RNA holding increased by 14587USD 1,247,1080USD 14,587 USD 31.205 USD 30.84
2025-04-25 (Friday)39,965USD 1,232,521RNA holding decreased by -3596USD 1,232,5210USD -3,596 USD 30.84 USD 30.93
2025-04-24 (Thursday)39,965RNA holding decreased by -270USD 1,236,117RNA holding increased by 1707USD 1,236,117-270USD 1,707 USD 30.93 USD 30.68
2025-04-23 (Wednesday)40,235USD 1,234,410RNA holding increased by 49489USD 1,234,4100USD 49,489 USD 30.68 USD 29.45
2025-04-22 (Tuesday)40,235USD 1,184,921RNA holding increased by 37419USD 1,184,9210USD 37,419 USD 29.45 USD 28.52
2025-04-21 (Monday)40,235USD 1,147,502RNA holding increased by 74837USD 1,147,5020USD 74,837 USD 28.52 USD 26.66
2025-04-18 (Friday)40,235USD 1,072,665USD 1,072,6650USD 0 USD 26.66 USD 26.66
2025-04-17 (Thursday)40,235RNA holding decreased by -135USD 1,072,665RNA holding increased by 32734USD 1,072,665-135USD 32,734 USD 26.66 USD 25.76
2025-04-16 (Wednesday)40,370USD 1,039,931RNA holding decreased by -37141USD 1,039,9310USD -37,141 USD 25.76 USD 26.68
2025-04-15 (Tuesday)40,370RNA holding decreased by -405USD 1,077,072RNA holding decreased by -20183USD 1,077,072-405USD -20,183 USD 26.68 USD 26.91
2025-04-14 (Monday)40,775RNA holding decreased by -405USD 1,097,255RNA holding increased by 43871USD 1,097,255-405USD 43,871 USD 26.91 USD 25.58
2025-04-11 (Friday)41,180USD 1,053,384RNA holding increased by 60534USD 1,053,3840USD 60,534 USD 25.58 USD 24.11
2025-04-10 (Thursday)41,180USD 992,850RNA holding decreased by -28414USD 992,8500USD -28,414 USD 24.11 USD 24.8
2025-04-09 (Wednesday)41,180RNA holding decreased by -540USD 1,021,264RNA holding increased by 16646USD 1,021,264-540USD 16,646 USD 24.8 USD 24.08
2025-04-08 (Tuesday)41,720USD 1,004,618RNA holding decreased by -58408USD 1,004,6180USD -58,408 USD 24.08 USD 25.48
2025-04-07 (Monday)41,720RNA holding decreased by -945USD 1,063,026RNA holding decreased by -70583USD 1,063,026-945USD -70,583 USD 25.48 USD 26.57
2025-04-04 (Friday)42,665RNA holding decreased by -1350USD 1,133,609RNA holding decreased by -176718USD 1,133,609-1,350USD -176,718 USD 26.57 USD 29.77
2025-04-02 (Wednesday)44,015USD 1,310,327RNA holding increased by 133366USD 1,310,3270USD 133,366 USD 29.77 USD 26.74
2025-04-01 (Tuesday)44,015USD 1,176,961RNA holding decreased by -122362USD 1,176,9610USD -122,362 USD 26.74 USD 29.52
2025-03-31 (Monday)44,015RNA holding increased by 135USD 1,299,323RNA holding decreased by -87285USD 1,299,323135USD -87,285 USD 29.52 USD 31.6
2025-03-28 (Friday)43,880USD 1,386,608RNA holding decreased by -42125USD 1,386,6080USD -42,125 USD 31.6 USD 32.56
2025-03-27 (Thursday)43,880USD 1,428,733RNA holding increased by 22379USD 1,428,7330USD 22,379 USD 32.56 USD 32.05
2025-03-26 (Wednesday)43,880USD 1,406,354RNA holding decreased by -2194USD 1,406,3540USD -2,194 USD 32.05 USD 32.1
2025-03-25 (Tuesday)43,880USD 1,408,548RNA holding decreased by -52656USD 1,408,5480USD -52,656 USD 32.1 USD 33.3
2025-03-24 (Monday)43,880USD 1,461,204RNA holding increased by 107945USD 1,461,2040USD 107,945 USD 33.3 USD 30.84
2025-03-21 (Friday)43,880USD 1,353,259RNA holding increased by 439USD 1,353,2590USD 439 USD 30.84 USD 30.83
2025-03-20 (Thursday)43,880USD 1,352,820RNA holding decreased by -39054USD 1,352,8200USD -39,054 USD 30.83 USD 31.72
2025-03-19 (Wednesday)43,880RNA holding decreased by -270USD 1,391,874RNA holding increased by 46182USD 1,391,874-270USD 46,182 USD 31.72 USD 30.48
2025-03-18 (Tuesday)44,150USD 1,345,692RNA holding decreased by -147903USD 1,345,6920USD -147,903 USD 30.48 USD 33.83
2025-03-17 (Monday)44,150USD 1,493,595RNA holding increased by 120088USD 1,493,5950USD 120,088 USD 33.83 USD 31.11
2025-03-14 (Friday)44,150RNA holding decreased by -810USD 1,373,507RNA holding decreased by -71058USD 1,373,507-810USD -71,058 USD 31.11 USD 32.13
2025-03-13 (Thursday)44,960RNA holding decreased by -270USD 1,444,565RNA holding decreased by -30385USD 1,444,565-270USD -30,385 USD 32.13 USD 32.61
2025-03-12 (Wednesday)45,230RNA holding decreased by -4590USD 1,474,950RNA holding increased by 1274USD 1,474,950-4,590USD 1,274 USD 32.61 USD 29.58
2025-03-11 (Tuesday)49,820USD 1,473,676RNA holding decreased by -22917USD 1,473,6760USD -22,917 USD 29.58 USD 30.04
2025-03-10 (Monday)49,820USD 1,496,593RNA holding decreased by -12455USD 1,496,5930USD -12,455 USD 30.04 USD 30.29
2025-03-07 (Friday)49,820RNA holding decreased by -270USD 1,509,048RNA holding decreased by -11184USD 1,509,048-270USD -11,184 USD 30.29 USD 30.35
2025-03-06 (Thursday)50,090RNA holding decreased by -405USD 1,520,232RNA holding increased by 28105USD 1,520,232-405USD 28,105 USD 30.35 USD 29.55
2025-03-05 (Wednesday)50,495USD 1,492,127RNA holding increased by 49990USD 1,492,1270USD 49,990 USD 29.55 USD 28.56
2025-03-04 (Tuesday)50,495USD 1,442,137RNA holding decreased by -33327USD 1,442,1370USD -33,327 USD 28.56 USD 29.22
2025-03-03 (Monday)50,495RNA holding decreased by -135USD 1,475,464RNA holding decreased by -75839USD 1,475,464-135USD -75,839 USD 29.22 USD 30.64
2025-02-28 (Friday)50,630RNA holding decreased by -810USD 1,551,303RNA holding increased by 55428USD 1,551,303-810USD 55,428 USD 30.64 USD 29.08
2025-02-27 (Thursday)51,440USD 1,495,875RNA holding decreased by -29321USD 1,495,8750USD -29,321 USD 29.08 USD 29.65
2025-02-26 (Wednesday)51,440RNA holding decreased by -135USD 1,525,196RNA holding increased by 21269USD 1,525,196-135USD 21,269 USD 29.65 USD 29.16
2025-02-25 (Tuesday)51,575RNA holding decreased by -405USD 1,503,927RNA holding decreased by -83022USD 1,503,927-405USD -83,022 USD 29.16 USD 30.53
2025-02-24 (Monday)51,980USD 1,586,949RNA holding decreased by -30669USD 1,586,9490USD -30,669 USD 30.53 USD 31.12
2025-02-21 (Friday)51,980USD 1,617,618RNA holding decreased by -73291USD 1,617,6180USD -73,291 USD 31.12 USD 32.53
2025-02-20 (Thursday)51,980USD 1,690,909RNA holding increased by 32747USD 1,690,9090USD 32,747 USD 32.53 USD 31.9
2025-02-19 (Wednesday)51,980USD 1,658,162RNA holding decreased by -5198USD 1,658,1620USD -5,198 USD 31.9 USD 32
2025-02-18 (Tuesday)51,980RNA holding increased by 675USD 1,663,360RNA holding increased by 5695USD 1,663,360675USD 5,695 USD 32 USD 32.31
2025-02-17 (Monday)51,305USD 1,657,665USD 1,657,6650USD 0 USD 32.31 USD 32.31
2025-02-14 (Friday)51,305USD 1,657,665RNA holding decreased by -36426USD 1,657,6650USD -36,426 USD 32.31 USD 33.02
2025-02-13 (Thursday)51,305RNA holding increased by 135USD 1,694,091RNA holding increased by 65350USD 1,694,091135USD 65,350 USD 33.02 USD 31.83
2025-02-12 (Wednesday)51,170RNA holding increased by 135USD 1,628,741RNA holding decreased by -95732USD 1,628,741135USD -95,732 USD 31.83 USD 33.79
2025-02-11 (Tuesday)51,035RNA holding increased by 405USD 1,724,473RNA holding decreased by -12642USD 1,724,473405USD -12,642 USD 33.79 USD 34.31
2025-02-10 (Monday)50,630USD 1,737,115RNA holding decreased by -30885USD 1,737,1150USD -30,885 USD 34.31 USD 34.92
2025-02-07 (Friday)50,630USD 1,768,000RNA holding decreased by -9619USD 1,768,0000USD -9,619 USD 34.92 USD 35.11
2025-02-06 (Thursday)50,630RNA holding increased by 1215USD 1,777,619RNA holding increased by 63907USD 1,777,6191,215USD 63,907 USD 35.11 USD 34.68
2025-02-05 (Wednesday)49,415USD 1,713,712RNA holding increased by 66216USD 1,713,7120USD 66,216 USD 34.68 USD 33.34
2025-02-04 (Tuesday)49,415USD 1,647,496RNA holding increased by 68193USD 1,647,4960USD 68,193 USD 33.34 USD 31.96
2025-02-03 (Monday)49,415USD 1,579,303RNA holding decreased by -47933USD 1,579,3030USD -47,933 USD 31.96 USD 32.93
2025-01-31 (Friday)49,415USD 1,627,236RNA holding increased by 14825USD 1,627,2360USD 14,825 USD 32.93 USD 32.63
2025-01-30 (Thursday)49,415USD 1,612,411RNA holding increased by 35084USD 1,612,4110USD 35,084 USD 32.63 USD 31.92
2025-01-29 (Wednesday)49,415USD 1,577,327RNA holding decreased by -7906USD 1,577,3270USD -7,906 USD 31.92 USD 32.08
2025-01-28 (Tuesday)49,415USD 1,585,233RNA holding increased by 81040USD 1,585,2330USD 81,040 USD 32.08 USD 30.44
2025-01-27 (Monday)49,415RNA holding increased by 135USD 1,504,193RNA holding increased by 42055USD 1,504,193135USD 42,055 USD 30.44 USD 29.67
2025-01-24 (Friday)49,280USD 1,462,138RNA holding decreased by -22668USD 1,462,1380USD -22,668 USD 29.67 USD 30.13
2025-01-23 (Thursday)49,280USD 1,484,806RNA holding increased by 2464USD 1,484,8060USD 2,464 USD 30.13 USD 30.08
2025-01-22 (Wednesday)49,280USD 1,482,342USD 1,482,342
2025-01-21 (Tuesday)49,550USD 1,528,122USD 1,528,122
2025-01-20 (Monday)49,550USD 1,432,986USD 1,432,986
2025-01-17 (Friday)49,550USD 1,432,986USD 1,432,986
2025-01-16 (Thursday)49,685USD 1,405,589USD 1,405,589
2025-01-15 (Wednesday)49,550USD 1,380,959USD 1,380,959
2025-01-14 (Tuesday)49,550USD 1,340,328USD 1,340,328
2025-01-13 (Monday)49,145USD 1,396,209USD 1,396,209
2025-01-10 (Friday)48,875USD 1,439,858USD 1,439,858
2025-01-09 (Thursday)48,875USD 1,462,829USD 1,462,829
2025-01-09 (Thursday)48,875USD 1,462,829USD 1,462,829
2025-01-09 (Thursday)48,875USD 1,462,829USD 1,462,829
2025-01-08 (Wednesday)48,875USD 1,462,829USD 1,462,829
2025-01-08 (Wednesday)48,875USD 1,462,829USD 1,462,829
2025-01-08 (Wednesday)48,875USD 1,462,829USD 1,462,829
2025-01-02 (Thursday)48,065USD 1,498,667RNA holding increased by 96130USD 1,498,6670USD 96,130 USD 31.18 USD 29.18
2024-12-30 (Monday)48,065RNA holding increased by 675USD 1,402,537RNA holding decreased by -308242USD 1,402,537675USD -308,242 USD 29.18 USD 36.1
2024-12-10 (Tuesday)47,390USD 1,710,779RNA holding decreased by -35543USD 1,710,7790USD -35,543 USD 36.1 USD 36.85
2024-12-09 (Monday)47,390USD 1,746,322RNA holding decreased by -67293USD 1,746,3220USD -67,293 USD 36.85 USD 38.27
2024-12-06 (Friday)47,390RNA holding increased by 540USD 1,813,615RNA holding increased by 85787USD 1,813,615540USD 85,787 USD 38.27 USD 36.88
2024-12-05 (Thursday)46,850RNA holding increased by 135USD 1,727,828RNA holding decreased by -44072USD 1,727,828135USD -44,072 USD 36.88 USD 37.93
2024-12-04 (Wednesday)46,715RNA holding increased by 675USD 1,771,900RNA holding increased by 281USD 1,771,900675USD 281 USD 37.93 USD 38.48
2024-12-03 (Tuesday)46,040USD 1,771,619RNA holding decreased by -129833USD 1,771,6190USD -129,833 USD 38.48 USD 41.3
2024-12-02 (Monday)46,040USD 1,901,452RNA holding decreased by -79649USD 1,901,4520USD -79,649 USD 41.3 USD 43.03
2024-11-29 (Friday)46,040RNA holding increased by 675USD 1,981,101RNA holding increased by 15436USD 1,981,101675USD 15,436 USD 43.03 USD 43.33
2024-11-28 (Thursday)45,365USD 1,965,665USD 1,965,6650USD 0 USD 43.33 USD 43.33
2024-11-27 (Wednesday)45,365RNA holding increased by 540USD 1,965,665RNA holding increased by 2330USD 1,965,665540USD 2,330 USD 43.33 USD 43.8
2024-11-26 (Tuesday)44,825RNA holding increased by 135USD 1,963,335RNA holding decreased by -53525USD 1,963,335135USD -53,525 USD 43.8 USD 45.13
2024-11-25 (Monday)44,690RNA holding increased by 2816USD 2,016,860RNA holding increased by 205809USD 2,016,8602,816USD 205,809 USD 45.13 USD 43.25
2024-11-22 (Friday)41,874USD 1,811,051RNA holding increased by 28894USD 1,811,0510USD 28,894 USD 43.25 USD 42.56
2024-11-21 (Thursday)41,874RNA holding increased by 635USD 1,782,157RNA holding decreased by -17925USD 1,782,157635USD -17,925 USD 42.56 USD 43.65
2024-11-20 (Wednesday)41,239RNA holding increased by 381USD 1,800,082RNA holding increased by 32973USD 1,800,082381USD 32,973 USD 43.65 USD 43.25
2024-11-19 (Tuesday)40,858USD 1,767,109RNA holding increased by 77631USD 1,767,1090USD 77,631 USD 43.25 USD 41.35
2024-11-18 (Monday)40,858RNA holding increased by 1514USD 1,689,478RNA holding decreased by -149067USD 1,689,4781,514USD -149,067 USD 41.35 USD 46.73
2024-11-12 (Tuesday)39,344RNA holding increased by 1008USD 1,838,545RNA holding increased by 47487USD 1,838,5451,008USD 47,487 USD 46.73 USD 46.72
2024-11-08 (Friday)38,336RNA holding increased by 630USD 1,791,058RNA holding decreased by -354USD 1,791,058630USD -354 USD 46.72 USD 47.51
2024-11-07 (Thursday)37,706RNA holding increased by 1890USD 1,791,412RNA holding increased by 99464USD 1,791,4121,890USD 99,464 USD 47.51 USD 47.24
2024-11-06 (Wednesday)35,816RNA holding increased by 252USD 1,691,948RNA holding increased by 88367USD 1,691,948252USD 88,367 USD 47.24 USD 45.09
2024-11-05 (Tuesday)35,564USD 1,603,581RNA holding increased by 9603USD 1,603,5810USD 9,603 USD 45.09 USD 44.82
2024-11-04 (Monday)35,564USD 1,593,978RNA holding increased by 104913USD 1,593,9780USD 104,913 USD 44.82 USD 41.87
2024-11-01 (Friday)35,564USD 1,489,065RNA holding decreased by -13870USD 1,489,0650USD -13,870 USD 41.87 USD 42.26
2024-10-31 (Thursday)35,564RNA holding increased by 126USD 1,502,935RNA holding decreased by -28695USD 1,502,935126USD -28,695 USD 42.26 USD 43.22
2024-10-30 (Wednesday)35,438USD 1,531,630RNA holding decreased by -47842USD 1,531,6300USD -47,842 USD 43.22 USD 44.57
2024-10-29 (Tuesday)35,438USD 1,579,472RNA holding decreased by -40753USD 1,579,4720USD -40,753 USD 44.57 USD 45.72
2024-10-28 (Monday)35,438USD 1,620,225RNA holding increased by 21617USD 1,620,2250USD 21,617 USD 45.72 USD 45.11
2024-10-25 (Friday)35,438USD 1,598,608RNA holding decreased by -1418USD 1,598,6080USD -1,418 USD 45.11 USD 45.15
2024-10-24 (Thursday)35,438USD 1,600,026RNA holding decreased by -8859USD 1,600,0260USD -8,859 USD 45.15 USD 45.4
2024-10-23 (Wednesday)35,438USD 1,608,885RNA holding decreased by -70167USD 1,608,8850USD -70,167 USD 45.4 USD 47.38
2024-10-22 (Tuesday)35,438USD 1,679,052RNA holding increased by 23743USD 1,679,0520USD 23,743 USD 47.38 USD 46.71
2024-10-21 (Monday)35,438USD 1,655,309RNA holding decreased by -132538USD 1,655,3090USD -132,538 USD 46.71 USD 50.45
2024-10-18 (Friday)35,438USD 1,787,847USD 1,787,847
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of RNA by Blackrock for IE00B3VWM098

Show aggregate share trades of RNA

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-04-30SELL-135 32.650* 34.51 Profit of 4,658 on sale
2025-04-24SELL-270 30.930* 34.64 Profit of 9,352 on sale
2025-04-17SELL-135 26.660* 34.97 Profit of 4,721 on sale
2025-04-15SELL-405 26.680* 35.16 Profit of 14,239 on sale
2025-04-14SELL-405 26.910* 35.25 Profit of 14,276 on sale
2025-04-09SELL-540 24.800* 35.61 Profit of 19,227 on sale
2025-04-07SELL-945 25.480* 35.86 Profit of 33,885 on sale
2025-04-04SELL-1,350 26.570* 35.97 Profit of 48,554 on sale
2025-03-31BUY135 29.520* 36.23
2025-03-19SELL-270 31.720* 36.70 Profit of 9,910 on sale
2025-03-14SELL-810 31.110* 36.91 Profit of 29,898 on sale
2025-03-13SELL-270 32.130* 36.98 Profit of 9,984 on sale
2025-03-12SELL-4,590 32.610* 37.04 Profit of 170,025 on sale
2025-03-07SELL-270 30.290* 37.36 Profit of 10,088 on sale
2025-03-06SELL-405 30.350* 37.47 Profit of 15,176 on sale
2025-03-03SELL-135 29.220* 37.88 Profit of 5,113 on sale
2025-02-28SELL-810 30.640* 38.00 Profit of 30,776 on sale
2025-02-26SELL-135 29.650* 38.29 Profit of 5,169 on sale
2025-02-25SELL-405 29.160* 38.44 Profit of 15,570 on sale
2025-02-18BUY675 32.000* 39.09
2025-02-13BUY135 33.020* 39.48
2025-02-12BUY135 31.830* 39.64
2025-02-11BUY405 33.790* 39.76
2025-02-06BUY1,215 35.110* 40.09
2025-01-27BUY135 30.440* 41.73
2024-12-30BUY675 29.180* 43.15
2024-12-06BUY540 38.270* 43.76
2024-12-05BUY135 36.880* 44.00
2024-12-04BUY675 37.930* 44.21
2024-11-29BUY675 43.030* 44.61
2024-11-27BUY540 43.330* 44.72
2024-11-26BUY135 43.800* 44.76
2024-11-25BUY2,816 45.130* 44.74
2024-11-21BUY635 42.560* 44.93
2024-11-20BUY381 43.650* 45.01
2024-11-18BUY1,514 41.350* 45.34
2024-11-12BUY1,008 46.730* 45.25
2024-11-08BUY630 46.720* 45.15
2024-11-07BUY1,890 47.510* 44.96
2024-11-06BUY252 47.240* 44.77
2024-10-31BUY126 42.260* 45.41
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of RNA

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-05-08761,4952341,082,33170.4%
2025-05-07369,0262,438761,08948.5%
2025-05-06907,88215,5391,622,97055.9%
2025-05-05179,49617279,28364.3%
2025-05-02408,668802589,35969.3%
2025-05-01310,460106352,25588.1%
2025-04-30227,85353329,07569.2%
2025-04-29215,636220298,47172.2%
2025-04-28183,870253265,80169.2%
2025-04-25223,6705,721359,71762.2%
2025-04-24233,079439509,60145.7%
2025-04-23393,822805485,61081.1%
2025-04-22542,024390881,75461.5%
2025-04-21399,3123,084553,97372.1%
2025-04-17299,969200780,33038.4%
2025-04-16290,460281398,63172.9%
2025-04-15203,633788431,61147.2%
2025-04-14208,090483391,04853.2%
2025-04-11319,8260435,22073.5%
2025-04-10299,2884,142598,75850.0%
2025-04-09535,49013,6021,557,58834.4%
2025-04-08569,28295861,34466.1%
2025-04-07432,834685816,52253.0%
2025-04-04507,72045799,82963.5%
2025-04-03664,6861541,011,47965.7%
2025-04-021,203,9036,2421,775,36667.8%
2025-04-01582,8282,4721,170,51149.8%
2025-03-311,090,8442681,592,24368.5%
2025-03-28233,043718272,76885.4%
2025-03-27460,852100524,23287.9%
2025-03-26487,1194,035541,42590.0%
2025-03-25328,4831,737410,01780.1%
2025-03-24370,2524,056403,38991.8%
2025-03-21200,226338248,23380.7%
2025-03-20363,7151,332629,76157.8%
2025-03-19187,68069362,61651.8%
2025-03-18415,9421,047557,40274.6%
2025-03-17384,71814,190557,38269.0%
2025-03-14434,2791,383549,31779.1%
2025-03-13471,2541,446747,05963.1%
2025-03-12356,1183,419533,69666.7%
2025-03-11246,772473349,12070.7%
2025-03-10206,439125294,19670.2%
2025-03-07227,754158326,61769.7%
2025-03-06231,25698370,43062.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.